Prevalence of mitochondrial diabetes in southwestern Finland: A molecular epidemiological study

Acta Diabetologica

Volumn 50, Issue 5, 2013, Pages 737-741

  Martikainen, Mika H ^a   Rönnemaa, Tapani ^a   Majamaa, Kari ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Diabetes mellitus; Epidemiology of mitochondrial disease; Hearing loss; Mitochondrial diabetes and deafness (MIDD)

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; BLOOD SAMPLING; DISEASE SEVERITY; FEMALE; FINLAND; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNALLY INHERITED DIABETES AND DEAFNESS; MOLECULAR EPIDEMIOLOGY; MUTATION; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; DIABETES MELLITUS; DNA, MITOCHONDRIAL; FEMALE; FINLAND; GENE FREQUENCY; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; MOLECULAR EPIDEMIOLOGY; POINT MUTATION; PREVALENCE; YOUNG ADULT;

EID: 84885418736     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-012-0393-2     Document Type: Article

References (35)

1. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368-371
2. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC (1992) Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-1379
3. Leu(UUR) mutation. Neurology 43:1015-1020
4. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y, Hayakawa T, Matsuoka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaki Y (1994) A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330:962-968
5. Leu(UUR) gene. Diabetes 43:746-751
6. Maassen JA (2002) Mitochondrial diabetes: pathophysiology, clinical presentation, and genetic analysis. Am J Med Genet 115:66-70
7. Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651-653
8. Murphy R, Turnbull DM, Walker M, Hattersley AT (2008) Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A > G mitochondrial point mutation. Diabet Med 25:383-399
9. Lehto M, Wipemo C, Ivarsson SA, Lindgren C, Lipsanen-Nyman M, Weng J, Wibell L, Widén E, Tuomi T, Groop L (1999) High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes. Diabetologia 42:1131-1137
10. Guillausseau PJ, Massin P, Dubois-LaForgue D, Timsit J, Virally M, Gin H, Bertin E, Blickle JF, Bouhanick B, Cahen J, Caillat-Zucman S, Charpentier G, Chedin P, Derrien C, Ducluzeau PH, Grimaldi A, Guerci B, Kaloustian E, Murat A, Olivier F, Paques M, Paquis-Flucklinger V, Porokhov B, Samuel-Lajeunesse J, Vialettes B (2001) Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 134:721-728
11. Wallace DC, Brown MD, Lott MT (1999) Mitochondrial DNA variation in human evolution and disease. Gene 238:211-230
12. Chinnery PF, Mowbray C, Patel SK, Elson JL, Sampson M, Hitman GA, McCarthy MI, Hattersley AT, Walker M (2007) Mitochondrial DNA haplogroups and type 2 diabetes: a study of 897 cases and 1010 controls. J Med Genet. doi: 10.1136/jmg.2007.048876
13. Mohlke KL, Jackson AU, Scott LJ, Peck EC, Suh YD, Chines PS, Watanabe RM, Buchanan TA, Conneely KN, Erdos MR, Narisu N, Enloe S, Valle TT, Tuomilehto J, Bergman RN, Boehnke M, Collins FS (2005) Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Hum Genet 118:245-254
14. Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M, Goethem GV, Lofgren A, Hackman P, Paetau A, Kaakkola S, Majamaa K, Varilo T, Udd B, Kaariainen H, Bindoff LA, Suomalainen A (2005) Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77:430-441
15. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Kärppä M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE (1998) Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and stroke like episodes: prevalence of the mutation in an adult population. Am J Hum Genet 63:447-454
16. Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, Scozzari R, Obinu D, Savontaus ML, Wallace DC (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144:1835-1850
17. Leu(UUR) gene mutation in Japanese patients. Diabetologia 37:504-510
18. Newkirk JE, Taylor RW, Howell N, Bindoff LA, Chinnery PF, Alberti KG, Turnbull DM, Walker M (1997) Maternally inherited diabetes and deafness: prevalence in a hospital diabetic population. Diabet Med 14:457-460
19. Leu(UUR) region. Diabet Med 14:1032-1037
20. Maassen JA, Janssen GMC, t'Hart LM (2005) Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med 37:213-221
21. Shanske S, Pancrudo J, Kaufmann P, Engelstad K, Jhung S, Lu J, Naini A, DiMauro S, De Vivo DC (2004) Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet 130A:134-137
22. Rahman S, Poulton J, Marchington D, Suomalainen A (2001) Decrease of 3243 A → G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet 68:238-240
23. Smith ML, Hua XY, Marsden DL, Liu D, Kennaway NG, Ngo KY, Haas RH (1997) Diabetes and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS): radiolabeled polymerase chain reaction is necessary for accurate detection of low percentages of mutation. J Clin Endocrinol Metab 82:2826-2831
24. Wong LJ, Lam CW (1997) Alternative, noninvasive tissues for quantitative screening of mutant mitochondrial DNA. Clin Chem 43:1241-1243
25. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14. Appendix
26. Hirano M, Ricci E, Rowland LP, De Vivo DC, DiMauro S (1991) Clinical definition of MELAS. (Abstract). Ann Neurol 30:299
27. Takeshima T, Nakashima K (2005) MIDD and MELAS: a clinical spectrum. Intern Med 44:276-277
28. Suzuki S, Oka Y, Kadowaki T, Kanatsuka A, Kuzuya T, Kobayashi M, Sanke T, Seino Y, Nanjo K, Research Committee for Specific Types of Diabetes Mellitus with Gene Mutations of the Japan Diabetes Society (2003) Clinical features of diabetes mellitus with the mitochondrial DNA 3243 (A-G) mutation in Japanese: maternal inheritance and mitochondria-related complications. Diabetes Res Clin Pract 59:207-217
29. Guéry B, Choukroun G, Noël LH, Clavel P, Rötig A, Lebon S, Rustin P, Bellané-Chantelot C, Mougenot B, Grünfeld JP, Chauveau D (2003) The Spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 14:2099-2108
30. Jansen JJ, Maassen JA, van der Woude FJ, Lemmink HA, van den Ouweland JM, t'Hart LM, Smeets HJ, Bruijn JA, Lemkes HH (1997) Mutation in mitochondrial tRNALeu(UUR) gene associated with progressive kidney disease. J Am Soc Nephrol 8:1118-1124
31. Nakamura S, Yoshinari M, Doi Y, Yoshizumi H, Katafuchi R, Yokomizo Y, Nishiyama K, Wakisaka M, Fujishima M (1999) Renal complications in patients with diabetes mellitus associated with an A to G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Diabetes Res Clin Pract 44:183-189
32. Narbonne H, Paquis-Fluckinger V, Valero R, Heyries L, Pellissier JF, Vialettes B (2004) Gastrointestinal tract symptoms in maternally inherited diabetes and deafness (MIDD). Diabetes Metab 30:61-66
33. Majamaa K, Finnilä S, Turkka J, Hassinen IE (1998) Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet 352:455-456
34. Martikainen MH, Majamaa K (2010) Epidemiology and characteristics of occipital brain infarcts in young adults in Southwestern Finland. J Neurol 257:259-263
35. Achilli A, Olivieri A, Pala M, Kashani BH, Carossa V, Perego UA, Gandini F, Santoro A, Battaglia V, Grugni V, Lancioni H, Sirolla C, Bonfigli AR, Cormio A, Boemi M, Testa I, Semino O, Ceriello A, Spazzafumo L, Gadaleta MN, Marra M, Testa R, Franceschi C, Torroni A (2011) Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a Whole. PLoS One. doi: 10.1371/journal.pone.0021029